Targeting cancer cells: Magnetic nanoparticles as drug carriers

European Biophysics Journal

Volumn 35, Issue 5, 2006, Pages 446-450

  Alexiou, Christoph ^a   Schmid, Roswitha J ^a   Jurgons, Roland ^a   Kremer, Marcus ^b   Wanner, Gerhard ^c   Bergemann, Christian ^d   Huenges, Ernst ^e   Nawroth, Thomas ^e   Arnold, Wolfgang ^e   Parak, Fritz G ^e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Chemicell   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biological tissue; Cell biophysics; Microscopy

Indexed keywords

DRUG CARRIER; IRON OXIDE; MITOXANTRONE; NANOPARTICLE; PHOSPHATE; STARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG TARGETING; ELECTRON MICROSCOPY; MAGNETIC FIELD; MAGNETISM; NONHUMAN; RABBIT; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MAGNETICS; MITOXANTRONE; NANOPARTICLES; RABBITS; TREATMENT OUTCOME;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33646442910     PISSN: 01757571     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00249-006-0042-1     Document Type: Article

References (7)

1. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lübbe AS (2000) Locoregional cancer treatment with magnetic drug targeting Cancer Res 60:6641-6648
2. Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhardt W, Huenges E, Parak FG (2003) Magnetic drug targeting - biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment J Drug Target 11:139-149
3. Bergemann C (1998) Magnetische Flüssigkeiten für den Transport von diagnostisch und therapeutisch wirksamen Substanzen Deutsches Patentamt, Offenlegungsschrift DE 19624426 A1
4. Langer R, (2001) Drug delivery: drugs on target Science 293:58-59
5. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D (1996a) Preclinical experiences with magnetic drug targeting: tolerance and efficacy Cancer Res 56:4694-4701
6. Lübbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dorken B, Herrmann F, Gurtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke A-J, Ohlendorf D, Huhnt W, Huhn D (1996b) Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors Cancer Res. 56:4686-4693
7. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity Am J Roentgenol 152:167-173